l carnitine warning L-CARNITINE 500 mg Potential Adverse Effects of L-Carnitine

The SURMOUNT-1 Phase 3 trial published in the New England Journal of Medicine demonstrated 20.9% mean body weight reduction at 72 weeks on tirzepatide 15mg weekly versus 3.1% with placebo

REDEFINE 1 adults with overweight/obesity, no diabetes GI adverse events were reported in 79.6% of CagriSema participants vs 39.9% on placebo

The use of nucleic acids or nucleic acid analogues that may alter genome sequences and/ or alter gene expression by any mechanism

DATS also inhibited LPS-induced NF-B-dependent expression of COX-2, iNOS, tumor necrosis factor- (TNF-), and interleukin-1 (IL-1) (37)

The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials